| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology and Immunology, University of South Alabama, Mobile, Alabama 36688
Both simian virus 40 (SV40)-induced viral oncogenesis and the transplantation of SV40-transformed tumor cells in hamsters can be prevented by the immunization of animals with intact fetal cells from primiparous females. The fetal determinants responsible for inducing transplantation resistance are temporally expressed on the surface of intact embryonic cells through the 11th day of gestation and are no longer detectable thereafter by direct immunization techniques. We now report that crude plasma membrane preparations from both 10-day-old and 14-day-old fetal cells and 3 M KCl extracts of these membranes are capable of inducing similar protection in hamsters against a challenge with SV40-transformed hamster sarcoma cells. In addition, spleen cells from adult hamsters immunized against SV40 tumor surface antigens will undergo a proliferative response in vitro in the presence of homologous tumor cells and 10-day-old fetal cells but not 14-day-old fetal cells. These results confirm the observation that midgestation hamster embryo cells express antigen(s) that is cross-reactive with the tumor-associated transplantation antigen(s) on SV40-transformed hamster sarcoma cells. Splenocytes sensitized to SV40 tumor surface antigens will proliferate in the presence of the plasma membranes from hamster sarcoma cells, 10-day-old and 14-day-old fetal cells, or 3 M KCl extracts of these membranes. Such sensitized splenocytes will not proliferate in the presence of the intact heterologous chemically transformed tumor cells, their plasma membranes, or 3 M KCl extracts or their plasma membranes. These findings suggest that such fetal determinants reside cryptically within the membranes of term embryo tissue even though their antigenicity and immunogenicity is restricted.
1 This study was supported in part by Grant CA 22674 from the National Cancer Institute and ERDA Contract EE 77-S05-5601.
Received 9/ 4/79. Accepted 1/23/80.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |